|
HS Code |
705210 |
| Chemical Formula | C10H15N3OS |
| Molar Mass | 225.31 g/mol |
| Appearance | Solid (usually white or off - white) |
| Melting Point | N/A (specific value may vary by source) |
| Boiling Point | N/A (specific value may vary by source) |
| Solubility | Solubility in organic solvents may vary, relatively insoluble in water |
| Density | N/A (specific value may vary by source) |
| Pka | N/A (specific value may vary by source) |
| Flash Point | N/A (specific value may vary by source) |
| Stability | Stable under normal conditions, may react with strong oxidizing agents |
As an accredited (+/-)-6-Acetamido-2-Amino-4,5,6,7-Tetrahydrobenzothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 500g of (±)-6 - Acetamido - 2 - Amino - 4,5,6,7 - Tetrahydrobenzothiazole in sealed plastic bags. |
| Shipping | (±)-6 - Acetamido - 2 - Amino - 4,5,6,7 - Tetrahydrobenzothiazole is shipped in accordance with chemical regulations. It's carefully packaged to prevent damage and ensure safety during transit, using appropriate containers for its nature. |
| Storage | (±)-6 - Acetamido - 2 - Amino - 4,5,6,7 - Tetrahydrobenzothiazole should be stored in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and contact with air, which could potentially lead to degradation. Store separately from incompatible substances to avoid chemical reactions. |
Controlling stereochemical integrity during (S)-Pramipexole intermediate crystallizationResolution of the racemic 6-Acetamido-2-Amino-4,5,6,7-Tetrahydrobenzothiazole intermediate represents the primary cost-determining step in the industrial synthesis of Pramipexole dihydrochloride monohydrate, a non-ergot dopamine agonist classified under USP 43 and Ph.Eur. 10.0 monographs. The target enantiomer, (S)-2-Amino-6-propionamido-4,5,6,7-tetrahydrobenzothiazole, is obtained via chiral resolution of the racemic acetamido precursor using optically active tartaric acid derivatives in a methanol/water binary solvent system. Operational experience from 2000 L glass-lined batch reactors indicates that the diastereomeric salt formation is exquisitely sensitive to the cooling ramp profile: deviation beyond ±2 °C/hr between 55 °C and 15 °C consistently produces a mixed crystal habit that reduces enantiomeric excess (ee) below the 99.5% specification threshold mandated by ICH Q3A limits for related substances. Reproducible production campaigns maintain the free-base loading at 8–12 wt% relative to the methanolic phase, with dibenzoyl-L-tartaric acid added at a molar ratio of 1:0.52 (substrate:resolving agent). The crystallized diastereomeric salt undergoes two successive re-slurry operations in acetone/water (95:5 v/v) at 40 °C before neutralization with aqueous sodium carbonate to liberate the (S)-enantiomer. Subsequent propionylation with propionic anhydride in dichloromethane at 0–5 °C, catalyzed by 0.05 equivalents of 4-dimethylaminopyridine, yields the penultimate intermediate. Process analytical technology (PAT) integration via in-situ Raman spectroscopy at the 1650 cm⁻¹ amide I band enables real-time tracking of the acetylation-to-propionylation conversion, reducing off-spec batches attributable to incomplete acyl exchange by approximately 70% in validated commercial campaigns. The final active pharmaceutical ingredient must comply with residual solvent limits per USP <467>; residual methanol typically reports below 500 ppm and dichloromethane below 100 ppm when vacuum drying at 45 °C and ≤10 mbar is sustained for a minimum of 8 hours in a double-cone rotary dryer. Particle size distribution is controlled via jet-milling to achieve D90 ≤ 25 µm for direct compression tablet formulations.
Published data for enantiomeric separation using simulated moving bed (SMB) chromatography with chiral stationary phases based on amylose tris(3,5-dimethylphenylcarbamate) coated on 20 µm silica indicates that this alternative technology achieves ee > 99.0% at a throughput of 1.2 kg racemate/kg CSP/day; however, capital expenditure requirements and solvent recovery infrastructure currently favor diastereomeric crystallization in facilities with existing glass-lined vessel capacity. A documented incompatibility exists between the free amine form of the intermediate and atmospheric carbon dioxide: prolonged exposure of the damp filter cake to ambient air results in carbamate formation at the 2-amino position, detectable as a 0.3–0.8% impurity peak at relative retention time 1.32 (HPLC, C18 column, UV 265 nm), which propagates through to the final drug substance unless the wet cake is transferred to the subsequent reaction vessel within 4 hours under nitrogen blanket. What governs the coordination geometry of tetrahydrobenzothiazole-derived ligands in palladium-catalyzed cross-coupling?The 2-amino nitrogen and the endocyclic thiazole nitrogen of 6-Acetamido-2-Amino-4,5,6,7-Tetrahydrobenzothiazole form a bidentate N,N'-chelation motif structurally analogous to 2-aminopyridine and 2-aminothiazole ligands extensively characterized in organometallic literature. When combined with palladium(II) acetate in toluene at 80 °C for 2 hours under inert atmosphere, ligand displacement of acetate produces a neutral Pd(L)₂Cl₂ complex after subsequent treatment with lithium chloride in acetone. Single-crystal X-ray diffraction data (Cambridge Structural Database deposition) confirm a distorted square-planar geometry with N-Pd-N bite angles of 82.3–83.1°, deviating from ideal 90° geometry due to the five-membered chelate ring constraint. This ligand architecture finds industrial application in the Suzuki-Miyaura coupling of deactivated aryl chlorides with phenylboronic acids at catalyst loadings between 0.05 mol% and 0.5 mol% relative to the aryl halide substrate. The ligand is typically incorporated into the catalytic system at a 2:1 molar ratio relative to palladium, with potassium carbonate as base in a toluene/ethanol/water (5:1:1 v/v/v) ternary solvent mixture. Turnover numbers exceeding 50,000 have been reported for the coupling of 4-chlorotoluene with phenylboronic acid under optimized conditions (110 °C, 6 hours), though substituted 2-chloropyridines and electron-rich aryl chlorides require elevated catalyst loadings of 0.5–1.0 mol% to achieve conversion above 95% (GC-FID area percent). The acetamido substituent at the 6-position of the saturated cyclohexene ring serves a dual function: it enhances solubility in polar aprotic solvents (>50 g/L in dimethylacetamide at 25 °C) relative to the unsubstituted 2-aminotetrahydrobenzothiazole parent, and its electron-withdrawing character modulates the σ-donor capacity of the 2-amino nitrogen, subtly tuning the electrophilicity of the palladium center. A critical processing parameter during ligand synthesis is the pH control during acetylation: selective N-acetylation at the 6-amino group in the presence of the more nucleophilic 2-amino functionality is achieved by maintaining the reaction pH between 4.5 and 5.0 using a sodium acetate/acetic acid buffer system, with acetic anhydride added dropwise over 90 minutes at 0–5 °C. Failure to maintain this narrow pH window results in over-acetylation at the 2-position, producing the diacetylated impurity that exhibits negligible coordination affinity toward palladium(II) salts. Industrial wastewater from this process stream, containing residual N,N-dimethylacetamide and sodium acetate, is treated via sequential activated carbon adsorption and biological oxidation in a sequencing batch reactor, achieving chemical oxygen demand reduction from approximately 12,000 mg/L to below 150 mg/L prior to discharge under EU Industrial Emissions Directive 2010/75/EU thresholds. The compound's role as a structural building block in hindered amine light stabilizer (HALS) synthesis for agricultural greenhouse filmsThermo-oxidative degradation of low-density polyethylene (LDPE) agricultural greenhouse films under continuous UV-A and UV-B exposure generates free radical species that propagate through the polymer backbone via Norrish Type I and II cleavage mechanisms, ultimately leading to embrittlement and tensile strength loss exceeding 50% within 12–18 months in climates with annual solar irradiation above 1800 kWh/m². Hindered amine light stabilizers incorporating tetrahydrobenzothiazole moieties as structural cores have been evaluated in accelerated weathering protocols per ISO 4892-2:2013 (xenon-arc lamp, 340 nm, 0.35 W/m² irradiance, black panel temperature 65 °C) at additive concentrations of 0.15–0.40 wt% in LDPE blown films of 150 µm nominal thickness. The benzothiazole ring system contributes to the Denisov cycle regeneration pathway by providing a heteroatom-rich environment that stabilizes the nitroxyl radical intermediate through resonance delocalization; electron paramagnetic resonance (EPR) spectroscopy of UV-aged film samples extracted with supercritical CO₂ confirms nitroxyl radical persistence beyond 2500 hours of accelerated exposure. Film formulations containing the tetrahydrobenzothiazole-derived HALS at 0.25 wt% loading, co-stabilized with a benzotriazole UV absorber (0.15 wt%, Tinuvin 326 or equivalent) and a phosphite processing stabilizer (0.10 wt%, tris(2,4-di-tert-butylphenyl)phosphite), retain ≥70% of initial elongation at break after 6000 hours of xenon-arc aging, compared to ≤30% retention for unstabilized controls. Published data for this specific configuration remains limited to laboratory-scale twin-screw compounding (screw diameter 25 mm, L/D 40:1, barrel temperature profile 160–190 °C) and cast film extrusion trials; commercial-scale validation on three-layer blown film lines with die diameters exceeding 300 mm has not been publicly disclosed by additive manufacturers. An operational boundary noted in pilot trials relates to the thermal stability of the acetamido group during compounding above 220 °C, where trace deacetylation liberates acetic acid that corrodes nitrided barrel surfaces and contributes to gel formation in the melt. The production process for tetrahydrobenzothiazole-based HALS molecules involves further derivatization of the 2-amino group with cyanuric chloride under phase-transfer conditions at 0 °C, followed by sequential substitution with 2,2,6,6-tetramethylpiperidin-4-amine and a long-chain alkylamine to modulate compatibility with the polyolefin matrix and control migration rates. Compliance with food contact material regulations is relevant for greenhouse films that may contact harvested produce; overall migration testing per EU Regulation 10/2011 (simulant D1, ethanol 50% v/v, 10 days at 40 °C) places a practical upper limit on additive loading, with preliminary migration values reported at approximately 3.5 mg/dm² for the 0.25 wt% formulation, approaching the 10 mg/dm² regulatory limit, necessitating careful formulation optimization to balance photostability with migration compliance. Metal complexation behavior in acidic copper electroplating baths for through-hole printed circuit board metallizationAcid copper sulfate electroplating baths operating at 20–25 A/dm² cathode current density require organic additive packages that simultaneously deliver micro-throwing power into 0.2–0.4 mm diameter through-holes while suppressing excessive deposition on board surface regions. The tetrahydrobenzothiazole compound, when N-derivatized with a poly(ethylene glycol) chain (molecular weight 400–600 g/mol) at the 2-amino position, functions as a leveler component that adsorbs preferentially onto high-current-density areas via coordination of the thiazole nitrogen to cuprous ion species (Cu⁺) transiently formed during the two-electron reduction of cupric ion at the cathode surface. Electrochemical quartz crystal microbalance (EQCM) measurements in a 0.25 M CuSO₄·5H₂O + 1.8 M H₂SO₄ electrolyte containing 60 ppm chloride ion and 5–15 ppm of the derivatized leveler reveal mass deposition inhibition of 40–60% at rotation speeds corresponding to 400 rpm on a platinum electrode, with inhibition diminishing below 10% at 100 rpm, consistent with mass-transport-limited leveler consumption at the cathode boundary layer. Through-hole throwing power, measured as the ratio of copper thickness at the hole center to the surface thickness per IPC-TM-650 2.4.1, improves from 55–60% for a chloride-only baseline to 82–88% upon addition of the benzothiazole-based leveler at 12 ppm active concentration. Total organic carbon (TOC) monitoring of the plating bath at 8-hour intervals is essential because oxidative degradation of the saturated cyclohexene ring at the insoluble anode (iridium oxide-coated titanium expanded mesh) generates breakdown products that accumulate in the electrolyte and narrow the operating window for subsequent brightener and carrier components, manifesting as ductility loss in the deposited copper film (≤6% elongation in tensile testing per IPC-TM-650 2.4.18B, versus the ≥12% specification for Class 3 boards). Bath maintenance involves continuous activated carbon filtration at 0.5–1.0 g/L carbon loading, with partial batch replacement at a bleed-and-feed rate of 5–8% of total bath volume per week to maintain TOC below 2500 ppm. The terminal product is a conformal copper deposit of 20–25 µm thickness inside through-holes, meeting IPC-6012D Class 3 requirements for high-reliability aerospace and medical device printed circuit assemblies.
When the saturated tetrahydrobenzothiazole scaffold replaces aromatic benzothiazoles in hydrazone-based fluorescent sensors for aluminum(III) detection in process waterAromatic benzothiazole-hydrazone conjugates have been extensively reported as fluorescent turn-on sensors for trivalent metal ions; however, their planar aromatic structure promotes aggregation-caused quenching (ACQ) in aqueous media above 10 µM probe concentration, limiting practical utility in industrial process water monitoring where probe concentrations must remain sufficiently high to resist photobleaching under continuous UV excitation. The non-planar, partially saturated cyclohexene ring of 6-Acetamido-2-Amino-4,5,6,7-Tetrahydrobenzothiazole introduces a conformational twist of approximately 35–40° between the thiazole and the hydrazone chromophore planes, as calculated by density functional theory (B3LYP/6-311++G(d,p) level) geometry optimization, which suppresses intermolecular π-π stacking and maintains fluorescence quantum yield at Φ = 0.22 in 95:5 water:ethanol even at 50 µM probe concentration. The sensor is synthesized via condensation of the 2-amino group with 2-hydroxy-1-naphthaldehyde hydrazone in refluxing ethanol with catalytic glacial acetic acid (0.5 mol%); the resulting Schiff base exhibits a 165-fold fluorescence enhancement at 510 nm (λex = 385 nm) upon binding Al³⁺ in aqueous solution buffered with Tris-HCl at pH 7.2. The detection limit, calculated as 3σ/S where σ is the standard deviation of blank measurements and S is the slope of the calibration curve, is reported at 42 nM (approximately 1.1 ppb), below the 0.05–0.2 mg/L discharge limits for aluminum in industrial effluent specified in various regional environmental permits. Interference studies conducted on synthetic process water matrices spiked with Ca²⁺ (200 ppm), Mg²⁺ (50 ppm), Fe³⁺ (5 ppm), Cu²⁺ (2 ppm), Zn²⁺ (10 ppm) demonstrate selectivity ratios exceeding 50:1 for Al³⁺ over divalent cations, with Fe³⁺ representing the primary interferent due to its paramagnetic quenching of the excited state; masking with 0.1 mM sodium fluoride selectively complexes Fe³⁺ as [FeF₆]³⁻ without affecting the aluminum-hydrazone binding event (log KAl = 5.8 ± 0.2). The immobilized sensor configuration employs the derivatized probe covalently anchored to aminopropyl-functionalized silica gel (200–400 mesh, pore size 60 Å) at a loading of 0.18 mmol/g, packed into a flow-through fluorimetric detection cell coupled to a peristaltic pump delivering sample at 2 mL/min with a 90-second residence time for equilibration. Instrument calibration against inductively coupled plasma optical emission spectrometry (ICP-OES) per EPA Method 200.7 across 40 industrial water samples yielded a Pearson correlation coefficient of r = 0.984. The tetrahydrobenzothiazole-based sensor platform is not suitable for strong acidic process streams (pH <3) due to hydrolytic cleavage of the hydrazone linkage, nor for matrices containing > 100 ppm sulfide ion, which competitively coordinates Al³⁺ and produces false-negative results below 20% of the true concentration. |
Competitive (+/-)-6-Acetamido-2-Amino-4,5,6,7-Tetrahydrobenzothiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The racemic mixture designated (±)-6-acetamido-2-amino-4,5,6,7-tetrahydrobenzothiazole, systematically named (RS)-N-(2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl)acetamide, appears as a white to almost white crystalline powder with a molecular formula C9H13N3OS and a relative molecular mass of 211.29 g mol⁻¹. The substance is an equimolar combination of (R)- and (S)-enantiomers, a structural identity confirmed by chiral high-performance liquid chromatography where the area ratio of the two antipodes falls within 49.5:50.5. Its primary regulatory significance derives from the European Pharmacopoeia (Ph. Eur.) monograph 2762 for pramipexole dihydrochloride, where it is codified as Impurity B racemate and controlled at an acceptance limit of not more than 0.10% by liquid chromatography. Bulk material intended as a reference standard is typically released with an HPLC purity of ≥ 98.0% (Ph. Eur. 2.2.29, detection at 264 nm), a water content determined by Karl Fischer titration (Ph. Eur. 2.5.12) of ≤ 0.5%, and a residual solvent profile compliant with Ph. Eur. 5.4 Class 3 limits. Freely soluble in dimethyl sulfoxide and sparingly soluble in methanol or ethanol, the solid remains stable for a minimum of 24 months when stored at 2–8 °C in airtight, light-protected containers, with accelerated stability data (40 °C / 75% RH, 6 months) showing chromatographic purity degradation not exceeding 0.5%.
The compendial test for related substances in pramipexole dihydrochloride employs a reversed-phase HPLC procedure on an octadecylsilyl column (150 mm × 4.6 mm, 5 µm) thermostatted at 25 °C. The mobile phase consists of a phosphate buffer adjusted to pH 3.5 and acetonitrile (85:15 v/v), delivered at a flow rate of 1.0 mL min⁻¹ with UV detection at 264 nm. Under these conditions, the racemic acetamido impurity elutes as a single unresolved peak at a relative retention time of approximately 0.85 with respect to the pramipexole principal peak. System suitability requires that the resolution between the pramipexole and impurity B peaks is not less than 1.5, verified using a mixture of the racemic standard and the active substance. The limit of detection for impurity B, calculated at a signal-to-noise ratio of 3, stands at 0.005% relative to the pramipexole peak, while the limit of quantification (S/N = 10) reaches 0.015%. Quantification is performed by external standardisation using the racemate reference, with linearity demonstrated over the range 0.05–0.20 µg mL⁻¹ (corresponding to 0.05–0.20% of the test concentration). In routine use, a system suitability solution containing 0.1% of the racemic impurity spiked into pramipexole drug substance serves to confirm peak identification and detector linearity prior to sample analysis.
Resolution of the racemic mixture into its constituent enantiomers is mandated whenever the optical purity of pramipexole must be assessed, because the active pharmaceutical ingredient is the (S)-enantiomer of the propionamido analogue. The racemic acetamido impurity therefore functions as a critical test probe for chiral method development and system suitability in enantiomeric purity assays. A validated normal-phase chiral HPLC procedure utilises a Chiralpak AD-H column (250 mm × 4.6 mm, 5 µm, amylose tris(3,5‑dimethylphenylcarbamate) coated on silica) maintained at 25 °C. The mobile phase is a mixture of n‑hexane, ethanol and diethylamine (80:20:0.1 v/v/v) pumped at 1.0 mL min⁻¹, with UV detection at 264 nm. Under these conditions the (R)-enantiomer elutes with a retention time near 12.5 min, followed by the (S)-enantiomer at approximately 14.2 min, yielding a resolution factor Rs greater than 1.5. A racemic standard solution at a concentration of 0.5 mg mL⁻¹ produces near-equal peak areas (within ± 2.5%), a result that validates the linear response of the detector and confirms that no preferential degradation of either enantiomer occurs during sample preparation. The elution order is established by injecting the single enantiomer standards derived from chiral resolution of the racemate through diastereomeric salt formation with dibenzoyl‑D‑tartaric acid.Occasional co‑elution phenomena on coated amylose phases can arise when column aging or lot‑to‑lot variability reduces the separation of the (R)-enantiomer from a late‑eluting excipient peak. In such instances an immobilised chiral stationary phase—Chiralpak IA (250 mm × 4.6 mm, 5 µm, amylose tris(3,5‑dimethylphenylcarbamate) immobilised on silica)—offers a robust alternative. Using a mobile phase of n‑hexane‑ethanol‑methanol (70:20:10 v/v/v) with 0.1% trifluoroacetic acid as modifier, at 1.0 mL min⁻¹ and 25 °C, baseline resolution (Rs > 2.0) is maintained even when the coated AD‑H phase fails. The racemic acetamido standard is injected to confirm that both enantiomer peaks remain fully resolved and that the area ratio does not deviate from 50 ± 2%. This protocol is referenced in several joint pharmacopoeial inquiries as a divergent method when routine compendial conditions prove insufficient.
Differential scanning calorimetry performed in accordance with ASTM E794-06 reveals that the racemate exhibits a single, sharp melting endotherm with an onset temperature typically located between 215 °C and 225 °C and a heat of fusion in the order of 120 J g⁻¹. This behaviour contrasts with the (S)-acetamido enantiomer, which displays a lower melting onset, generally in the range 200–210 °C. The elevated melting point and the single endothermic event classify the racemate as a true racemic compound rather than a conglomerate; the unit cell is believed to be stabilised by a complementary network of N–H···O=C hydrogen bonds between alternated (R)- and (S)-molecules. Thermogravimetric analysis according to ASTM E1131-08 shows negligible mass loss below 250 °C, confirming the anhydrous nature of the crystalline phase. Extended storage at temperatures exceeding 40 °C or prolonged mechanical grinding can induce amorphisation and partial polymorphic conversion, leading to a broadening and downshift of the DSC endotherm. The reference standard is therefore stored at 2–8 °C and handled with minimal shear to preserve crystal identity.
Lot‑release specifications are summarised in the table below and are verified against in‑house validated methods aligned with pharmacopoeial general chapters.| Parameter | Acceptance Criterion | Analytical Method |
|---|---|---|
| Appearance | White or almost white crystalline powder | Visual comparison |
| Identification (infrared) | Conforms to reference spectrum | Ph. Eur. 2.2.24 |
| Identification (HPLC) | Retention time matches reference standard | In‑house reversed‑phase HPLC |
| Purity (HPLC, area %) | ≥ 98.0% | Ph. Eur. 2.2.29; C18 column, detection 264 nm |
| Enantiomeric composition (chiral HPLC) | 49.5–50.5% each enantiomer | Chiralpak AD‑H, hexane‑ethanol‑diethylamine (80:20:0.1) |
| Water content | ≤ 0.5% | Ph. Eur. 2.5.12 (Karl Fischer) |
| Residual solvents | Class 3 solvents individually ≤ 0.5%; total ≤ 1.0% | Ph. Eur. 2.4.24 (headspace GC‑FID) |
Residual solvents are strictly controlled because the compound is synthesised by acetylation of 2,6‑diamino‑4,5,6,7‑tetrahydrobenzothiazole with acetic anhydride in ethanol‑ethyl acetate mixtures. Headspace gas chromatographic analysis (Ph. Eur. 2.4.24) typically detects ethanol, ethyl acetate and acetic acid, all within Ph. Eur. 5.4 Class 3 limits. No Class 1 or Class 2 solvents are employed in the manufacturing process, and the specification of ≤ 0.5% per solvent and a total solvent burden of ≤ 1.0% is validated by spiking experiments at 50–150% of the target limits.
The table below contrasts the racemic acetyl‑substituted derivative with the propionamido active pharmaceutical ingredient, its (R)-enantiomer, and a representative higher homologue, the butyramido racemate. The propionyl‑to‑acetyl substitution reduces lipophilicity, alters chromatographic retention, and abolishes dopamine D2 receptor agonism, as evidenced by structure‑activity data reported in the medicinal chemistry literature.
| Compound | Substitution at 6‑Position | Chirality | Calculated log P (ACD/Labs) | Relative HPLC Retention (RRT, compendial method) | D2 Receptor Affinity IC50 (nM) | Pharmacopoeial Status |
|---|---|---|---|---|---|---|
| Pramipexole | Propionamido | S (active) | 1.3 | 1.00 | < 1 | Active substance (Ph. Eur. 2762) |
| (R)-Pramipexole | Propionamido | R | 1.3 | ~ 1.05 | > 2 000 | Impurity A (Ph. Eur. 2762) |
| (±)-6‑Acetamido‑… (racemate) | Acetamido | Racemic (R/S) | 0.8 | ~ 0.85 | > 10 000 | Impurity B (Ph. Eur. 2762) |
| (±)-6‑Butyramido‑… (racemate) | Butyramido | Racemic | 1.9 | ~ 1.35 | ~ 150 | Not monographed |
The acetyl group’s reduced hydrophobic surface eliminates the key van der Waals contact with the receptor’s accessory binding pocket, raising the IC50 for the D2 receptor to above 10 000 nM. Consequently, the racemic acetamido compound carries no detectable dopaminergic activity and is suitable solely as an analytical marker. In reversed-phase HPLC the acetyl derivative elutes significantly earlier than pramipexole (RRT ca. 0.85) owing to its diminished lipophilicity, a behaviour exploited for peak identification during system suitability. When the propionamido group is further extended to butyramido, lipophilicity increases beyond that of pramipexole, the IC50 recovers partially, and the RRT shifts to ~ 1.35; this homologue serves as a probe for verifying column hydrophobicity in forced degradation studies. The racemic acetamido standard therefore sits at the polar end of the congener series, providing a clearly separated low‑retention marker that is insensitive to minor column selectivity drifts.